, Tracking Stock Market Picks
Enter Symbol:
Magnum Hunter Resources Corporation (MHR) [hlAlert]

Mkt Outperform
down 30.53 %

Magnum Hunter Resources Corporation (MHR) rated Mkt Outperform with price target $8 by Rodman & Renshaw

Posted on: Thursday,  Dec 23, 2010  12:25 PM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Magnum Hunter Resources Corporation (NYSE: MHR) on 12/23/2010. Previously Rodman & Renshaw rated Mkt Outperform Magnum Hunter Resources Corporation
(NYSE: MHR) on 09/15/2009., when the stock price was $1.31. Since then, Magnum Hunter Resources Corporation has lost 30.53% as of 10/12/2015's recent price of $0.91.
If you would have followed the previous Rodman & Renshaw's recommendation on MHR, you would have lost 30.53% of your investment in 2218 days.

Magnum Hunter Resources Corporation, formerly Petro Resources Corporation, is an independent oil and gas company engaged in the acquisition, drilling and production of oil and natural gas properties and prospects within the United States. The acquisition and exploration pursuits of oil and natural gas properties are located in Texas, Louisiana, North Dakota, New Mexico and Kentucky. During the year ended December 31, 2008, the Company owned interests in approximately 286,282 gross (50,611 net) leasehold acres, of which 261,147 gross (43,281 net) acres are classified as undeveloped acreage. As of March 30, 2009, the Company held interests in approximately 238 producing wells in Texas, Louisiana and North Dakota. The Company?s drilling inventory includes prospects located in Texas, Louisiana, New Mexico, North Dakota and Kentucky. As of December 31, 2008, the total proved reserves of the Company were 3,118 thousand barrels of oil equivalent (mboe) net of production.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/28/2010 10:25 AM Buy
7.32 9.00
as of 12/31/2010
1 Week up  5.20 %
1 Month up  15.14 %
3 Months up  70.77 %
1 YTD up  356.12 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/23/2010 12:25 PM Buy
6.33 8.00
4/8/2010 8:25 AM Buy
3.72 4.75
9/15/2009 3:25 PM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy